Home/Filings/4/0001127602-17-034596
4//SEC Filing

Hampton Malcolm Garret 4

Accession 0001127602-17-034596

CIK 0001110803other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 8:28 PM ET

Size

7.1 KB

Accession

0001127602-17-034596

Insider Transaction Report

Form 4
Period: 2017-12-11
Hampton Malcolm Garret
EVP Clinical Genomics Group
Transactions
  • Award

    Common Stock

    2017-12-11+2,9206,453 total
  • Award

    Performance Shares

    2017-12-11+8,7588,758 total
    Exp: 2021-01-03Common Stock (8,758 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2018, November 5, 2019, November 5, 2020, and November 5, 2021, subject to awardee's continuing status as a service provider on such dates.
  • [F2]Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 3, 2021. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending January 3, 2021, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.

Issuer

ILLUMINA INC

CIK 0001110803

Entity typeother

Related Parties

1
  • filerCIK 0001698265

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 8:28 PM ET
Size
7.1 KB